Not Yet Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1
NCT06777264
- Conditions
- Acute Lymphoblastic Leukemia, B Cell ALL, Burkitt Lymphoma, +20 more
- Locations
-
Not specified